MIOX and nonpapillary renal cell carcinoma: Conversely, in clear cell renal cell carcinoma (ccRCC), MIOX was categorized as a cuproptosis-associated ferroptosis gene, with its downregulation in high-risk subgroups proposed to function as a protective factor predictive of patient prognosis [38].